SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-24-000192
Filing Date
2024-02-27
Accepted
2024-02-27 16:52:41
Documents
63
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q novaccess20231231_10q.htm   iXBRL 10-Q 920853
2 EXHIBIT 31.1 ex_628755.htm EX-31.1 8088
3 EXHIBIT 31.2 ex_628756.htm EX-31.2 7856
4 EXHIBIT 32.1 ex_628757.htm EX-32.1 3886
  Complete submission text file 0001185185-24-000192.txt   6115801

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20231231.xsd EX-101.SCH 50801
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xsnx-20231231_cal.xml EX-101.CAL 24085
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20231231_def.xml EX-101.DEF 273133
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20231231_lab.xml EX-101.LAB 420483
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20231231_pre.xml EX-101.PRE 278542
64 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20231231_10q_htm.xml XML 852468
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

IRS No.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-29621 | Film No.: 24687920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)